Company / Current Liabilities
Mirum Pharmaceuticals, Inc. Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$205.8M
FY2025
5-year range
$42.6M / $205.8M
FY2021-FY2025
Trend
+62.6%
vs FY2024
Sector context
#57 of 213
Health Care
What the data says
At $206M, Mirum Pharmaceuticals, Inc.'s current liabilities ranks #157 of 213 in the Health Care sector. Current Liabilities has increased for 7 consecutive years, from $2M in FY2018 to $206M in FY2025.
Based on SEC 10-K filings.
$206M in FY2025 with a 5-year CAGR of +62.0%.
Increased from $87M to $206M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +47.0%
- 5-Year CAGR
- +62.0%
- 10-Year CAGR
- -
Sector benchmark
#157 of 213 in Health CareTop 73% of 213This company $205.8M Sector average $1.6B
▼
-87.0% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s current liabilities has grown for 7 consecutive years.
- 5-year CAGR of +62.0%, indicating consistent growth.
- In FY2025, current liabilities increased 62.6% year-over-year.
- Ranks #57 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $205.8M | +62.6% |
| FY2024 | $126.6M | +45.4% |
| FY2023 | $87.1M | +34.5% |
| FY2022 | $64.7M | +52.0% |
| FY2021 | $42.6M | +130.7% |
| FY2020 | $18.5M | +41.2% |
| FY2019 | $13.1M | +433.9% |
| FY2018 | $2.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026